4.9 (666) · € 31.00 · Auf Lager
After a period of stagnant sales largely because of increased competition and pricing pressures, the generic drug industry took another hit during the coronavirus pandemic. In its 10-K annual report to the Securities and Exchange Commission, generics giant Teva described how the pandemic impacted sales of its copycat drugs. The company noted that "supply discontinuities due to regulatory actions, labor disturbances and approval delays" all affected its overall performance. The drugmaker likely wasn't alone. | Many producers of generic drugs have struggled to achieve growth in recent years due to pricing pressures. But there are promising signs that the industry is ready for an uptick, and they were evident in 2021 as eight of the top 10 companies by generics sales realized growth.
Generics top manufacturers by revenue worldwide 2022
Which is the leading pharmaceutical company in the world? - Quora
The top 20 pharma companies by 2021 revenue
Ivermectin for Covid Therapy Is Questionable, But Demand Is Soaring - Bloomberg
2023 Pharm Exec Top 50 Companies
Generic Pharmaceuticals Market Size, Share Analysis, Trends And Report 2033
25+ Incredible U.S. Pharmaceutical Statistics [2023]: Facts, Data, Trends And More - Zippia
A Comparison of Brand-Name Drug Prices Among Selected Federal Programs
The story of Alvogen and the founding of a pharma empire
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
These were the biggest pharmaceutical deals in early 2022 - Pharmaceutical Technology
Top Pharmaceutical Companies to watch in 2024 - GreyB